Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 21, 2025

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos
08:39

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos

Published on: August 31, 2016

5.7K

Engineering of Affibody Molecules.

Stefan Ståhl1, Hanna Lindberg2, Linnea Charlotta Hjelm2

  • 1Department of Protein Science, KTH Royal Institute of Technology, 106 91 Stockholm, Sweden ssta@kth.se.

Cold Spring Harbor Protocols
|July 25, 2023
PubMed
Summary

Affibody molecules are small protein binders with therapeutic and diagnostic potential. These engineered proteins offer advantages over antibodies for targeted applications in medicine and biotechnology.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biparatopic affibody engineering enables high-affinity sortilin blockade and progranulin elevation.

New biotechnology·2026
Same author

Trimerization of CD40L-specific affibody molecules using collagen domains enhances target binding and CD40 blockade.

Cellular and molecular life sciences : CMLS·2026
Same author

Combining bacterial display and protein language models to engineer a CD69-binding affibody for molecular imaging of immune activation.

Protein engineering, design & selection : PEDS·2026
Same author

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal of biological engineering·2026
Same author

Engineering affibody domains as anti-idiotypic masks for nivolumab-based prodrugs.

Protein engineering, design & selection : PEDS·2026
Same author

Increased affinity by dimerization of radiolabeled Affibody molecule ATH001 targeting PDGFRβ.

EJNMMI radiopharmacy and chemistry·2026

Area of Science:

  • Biotechnology
  • Protein Engineering
  • Molecular Medicine

Background:

  • Affibody molecules are small, robust affinity proteins.
  • They are being explored for therapeutic, diagnostic, and biotechnological uses.
  • They offer an alternative to antibody-based technologies.

Purpose of the Study:

  • To provide a background on affibody molecules.
  • To present examples of their applications.
  • To summarize affibody generation methodology.

Main Methods:

  • Combinatorial protein engineering of affibody scaffolds.
  • Randomization of surface-exposed residues.
  • Generation of large affibody libraries for novel binding specificities.

More Related Videos

Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray
09:05

Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray

Published on: January 6, 2016

14.6K
Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

16.8K

Related Experiment Videos

Last Updated: Jul 21, 2025

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos
08:39

Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos

Published on: August 31, 2016

5.7K
Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray
09:05

Flow-pattern Guided Fabrication of High-density Barcode Antibody Microarray

Published on: January 6, 2016

14.6K
Bridging the Bio-Electronic Interface with Biofabrication
16:38

Bridging the Bio-Electronic Interface with Biofabrication

Published on: June 6, 2012

16.8K

Main Results:

  • Affibody molecules demonstrate high stability, affinity, and specificity.
  • They exhibit efficient tissue penetration and modular extensibility.
  • Preclinical and clinical studies show safety and efficacy for in vivo applications.

Conclusions:

  • Affibody molecules are versatile and promising for targeted diagnostics and therapeutics.
  • They possess desirable properties that may surpass current antibody technologies.
  • Affibody generation is a viable method for creating novel binding proteins.